Clinical Trials Directory

Trials / Completed

CompletedNCT03830619

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The study is to investigate the sensitivity and specificity of serum exosome noncoding RNA as a biomarker for the diagnosis of lung cancer

Detailed description

Conventional tumor markers for non-invasive diagnosis of Lung cancer (LC) exhibit insufficient sensitivity and specificity to facilitate detection of early lung cancer (ELC). The investigators aimed to identify ELC-specific exosomal lncRNA biomarkers that are highly sensitive and stable for the non-invasive diagnosis of ELC.Hence, in the present study, exosomes from the plasma of five healthy individuals and 30 LC patients and from culture media of four human bronchial epithelial cells and four cancer cells were isolated. Exosomal RNA profiling was performed using RNA sequencing to identify LC specific exosomal lncRNAs.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTcollect samplescollect serum samples and clinical features

Timeline

Start date
2017-01-01
Primary completion
2020-12-31
Completion
2021-07-31
First posted
2019-02-05
Last updated
2021-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03830619. Inclusion in this directory is not an endorsement.